Pharmacists play a critical role in catching problematic generic medications that can cause therapeutic failure or adverse effects. Learn when and how to flag unsafe substitutions, especially with narrow therapeutic index drugs.
African-made antiretroviral generics are transforming HIV treatment access, with the first WHO-prequalified African-produced TLD drug delivered in 2025. Local production cuts costs, strengthens supply chains, and empowers health sovereignty.
Cystic fibrosis is a genetic disease causing thick mucus in the lungs and organs. New CFTR modulator drugs like Trikafta have transformed survival rates, but access and cost remain major barriers for many.
MAFLD is the most common liver disease worldwide-but it’s reversible. Learn how diet, exercise, and weight loss can heal your liver, what treatments actually work, and why most people don’t know they have it.
Learn the critical difference between serious and non-serious adverse events in clinical trials-and when each must be reported. Understand the six FDA criteria, avoid common mistakes, and ensure patient safety without overwhelming the system.